1. Home
  2. JKS vs NVCR Comparison

JKS vs NVCR Comparison

Compare JKS & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JinkoSolar Holding Company Limited (each representing 4)

JKS

JinkoSolar Holding Company Limited (each representing 4)

HOLD

Current Price

$21.35

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$12.61

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JKS
NVCR
Founded
2006
2000
Country
China
Switzerland
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
JKS
NVCR
Price
$21.35
$12.61
Analyst Decision
Hold
Buy
Analyst Count
4
6
Target Price
$25.25
$28.08
AVG Volume (30 Days)
463.3K
1.0M
Earning Date
04-16-2026
04-30-2026
Dividend Yield
5.37%
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
N/A
$7.72
Revenue Next Year
$37.42
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.28
52 Week Low
$15.55
$9.82
52 Week High
$31.88
$20.05

Technical Indicators

Market Signals
Indicator
JKS
NVCR
Relative Strength Index (RSI) 33.33 59.73
Support Level N/A $10.72
Resistance Level $26.33 $13.59
Average True Range (ATR) 1.13 0.55
MACD -0.17 0.20
Stochastic Oscillator 17.01 95.30

Price Performance

Historical Comparison
JKS
NVCR

About JKS JinkoSolar Holding Company Limited (each representing 4)

JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: